TARRYTOWN, N.Y., Jan. 10, 2020 /PRNewswire/ -- Regeneron
Pharmaceuticals, Inc. (NASDAQ: REGN) today announced
that it will report its fourth quarter and full year 2019 financial
and operating results on Thursday, February
6, 2020, before the U.S. financial markets open. The
Company will host a conference call and simultaneous webcast at
8:00 AM Eastern Time that day.
Conference Call Information
To access this call, dial
(800) 708-4540 (U.S.) or (847) 619-6397 (International). A
link to the webcast may be accessed from the 'Investors and Media'
page of Regeneron's website at
http://investor.regeneron.com/events.cfm. A replay of the
conference call and webcast will be archived on the Company's
website for at least 30 days.
About Regeneron
Regeneron (NASDAQ: REGN) is a leading
biotechnology company that invents life-transforming medicines for
people with serious diseases. Founded and led for 30 years by
physician-scientists, our unique ability to repeatedly and
consistently translate science into medicine has led to seven
FDA-approved treatments and numerous product candidates in
development, all of which were homegrown in our laboratories. Our
medicines and pipeline are designed to help patients with eye
diseases, allergic and inflammatory diseases, cancer,
cardiovascular and metabolic diseases, infectious diseases, pain
and rare diseases.
Regeneron is accelerating and improving the traditional drug
development process through our proprietary
VelociSuite® technologies, including
VelocImmune® which uses a unique
genetically-humanized mouse to produce optimized fully-human
antibodies and bispecific antibodies, and through ambitious
research initiatives such as the Regeneron Genetics Center, which
is conducting one of the largest genetics sequencing efforts in the
world.
For additional information about the company, please visit
www.regeneron.com or follow @Regeneron on Twitter.
Contact
Information:
|
|
Investor
Relations
|
Corporate
Communications
|
Justin
Holko
|
Hala Mirza
|
914.847.7786
|
914.847.3422
|
justin.holko@regeneron.com
|
hala.mirza@regeneron.com
|
View original
content:http://www.prnewswire.com/news-releases/regeneron-to-report-fourth-quarter-and-full-year-2019-financial-and-operating-results-and-host-conference-call-and-webcast-on-february-6-2020-300984444.html
SOURCE Regeneron Pharmaceuticals, Inc.